Cargando…

A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca

Keratoconjunctivitis sicca (KCS) is a multifactorial disease characterized by tear hyperosmolarity, inflammation, and ocular surface damage. Cyclosporine A (CsA) is used as an effective disease-modifying agent to improve the signs and symptoms of KCS by reducing inflammation, which interferes with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jerkins, Gary W, Pattar, Guruprasad R, Kannarr, Shane R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039096/ https://www.ncbi.nlm.nih.gov/pubmed/32109984 http://dx.doi.org/10.2147/OPTH.S228070

Ejemplares similares

Changes in tear protein profile in dogs with keratoconjunctivitis sicca following topical treatment using cyclosporine A
por: Sussadee, Metita, et al.
Publicado: (2021)

A New Conception of Keratoconjunctivitis Sicca
Publicado: (1946)

The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca
por: Gumus, Koray, et al.
Publicado: (2009)

Tear ferning in normal dogs and dogs with keratoconjunctivitis sicca
por: Williams, David, et al.
Publicado: (2017)

Effect of Oral Choline Alfoscerate on Patients with Keratoconjunctivitis Sicca
por: Choi, Jin Ju, et al.
Publicado: (2020)

Topical applications of allogeneic adipose-derived mesenchymal stem cells ameliorate the canine keratoconjunctivitis sicca
por: Wei, Li-Ning, et al.
Publicado: (2022)

Immune-mediated keratoconjunctivitis sicca in dogs: current perspectives on management
por: Dodi, Pier Luigi
Publicado: (2015)

Differentially Expressed Tear Proteins in Sjögren's Syndrome Keratoconjunctivitis Sicca
por: Yoon, Stephen P., et al.
Publicado: (2023)

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies
por: Malhotra, Ranjan, et al.
Publicado: (2019)

Comparison of topical 0.03% tacrolimus and homologous injectable platelet-rich plasma in the treatment of keratoconjunctivitis sicca in dogs
por: Estanho, Giovana José Garcia, et al.
Publicado: (2023)

Use of linseed oil to treat experimentally induced keratoconjunctivitis sicca in rabbits
por: Neves, Magda Luzia, et al.
Publicado: (2013)

Microvascular autologous submandibular gland transplantation in severe cases of keratoconjunctivitis sicca
por: Su, Jia-Zeng, et al.
Publicado: (2015)

Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca
por: de Paiva, Cintia S., et al.
Publicado: (2021)

Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
por: Bayraktutar, Betül N., et al.
Publicado: (2016)

Recurrent microbial keratitis in eyes with keratoconjunctivitis sicca with coexisting ocular surface pathology
por: Nanavaty, Mayank A., et al.
Publicado: (2014)

Use of Adipose-Derived Mesenchymal Stem Cells in Keratoconjunctivitis Sicca in a Canine Model
por: Villatoro, Antonio J., et al.
Publicado: (2015)

Immunohistochemical evaluation of lymphocyte populations in the nictitans glands of normal dogs and dogs with keratoconjunctivitis sicca
por: Williams, David L., et al.
Publicado: (2018)

Apricot Kernel Extract and Amygdalin Inhibit Urban Particulate Matter-Induced Keratoconjunctivitis Sicca
por: Hyun, Soo-Wang, et al.
Publicado: (2019)

Clinical evaluation of a nutraceutical diet as an adjuvant to pharmacological treatment in dogs affected by Keratoconjunctivitis sicca
por: Destefanis, Simona, et al.
Publicado: (2016)

Autonomic reinnervation and functional regeneration in autologous transplanted submandibular glands in patients with severe keratoconjunctivitis sicca
por: Zhang, Xueming, et al.
Publicado: (2018)

Severity of Sjögren’s Syndrome Keratoconjunctivitis Sicca Increases with Increased Percentage of Conjunctival Antigen-Presenting Cells
por: Pflugfelder, Stephen C., et al.
Publicado: (2018)

Treatment of patients with keratoconjunctivitis sicca with Optive™: results of a multicenter, open-label observational study in Germany
por: Kaercher, Thomas, et al.
Publicado: (2009)

Erratum to: Clinical evaluation of a nutraceutical diet as an adjuvant to pharmacological treatment in dogs affected by Keratoconjunctivitis sicca
por: Destefanis, Simona, et al.
Publicado: (2016)

Ocular Clinical Signs and Diagnostic Tests Most Compatible With Keratoconjunctivitis Sicca: A Latent Class Approach
por: Gonzales, John A., et al.
Publicado: (2020)

Reproducibility of Ocular Surface Staining in the Assessment of Sjögren Syndrome–Related Keratoconjunctivitis Sicca: Implications on Disease Classification
por: Rasmussen, Astrid, et al.
Publicado: (2019)

Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial
por: Rao, A Tarakeswara, et al.
Publicado: (2023)

Disruption of TGF-β Signaling Improves Ocular Surface Epithelial Disease in Experimental Autoimmune Keratoconjunctivitis Sicca
por: De Paiva, Cintia S., et al.
Publicado: (2011)

Comparison between fish and linseed oils administered orally for the treatment of experimentally induced keratoconjunctivitis sicca in rabbits
por: Silva, Danielle Alves, et al.
Publicado: (2017)

Assessment of meibomian gland morphology by noncontact infrared meibography in Shih Tzu dogs with or without keratoconjunctivitis sicca
por: Kitamura, Yasunari, et al.
Publicado: (2019)

Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis
por: Gokhale, Nikhil S, et al.
Publicado: (2012)

Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children
por: Chatterjee, Arkendu, et al.
Publicado: (2019)

Comparison of hyaluronic acid-containing topical eye drops with carbomer-based topical ocular gel as a tear replacement in canine keratoconjunctivitis sicca: A prospective study in twenty five dogs
por: Williams, David, et al.
Publicado: (2012)

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials
por: Leonardi, Andrea, et al.
Publicado: (2022)

Tear Ferning Test and Pathological Effects on Ocular Surface before and after Topical Cyclosporine in Vernal Keratoconjunctivitis Patients
por: Nebbioso, Marcella, et al.
Publicado: (2018)

Polyparaneoplastic Manifestations of Malignant Thymoma: A Unique Case of Myasthenia, Autoimmune Hepatitis, Pure Red Cell Aplasia, and Keratoconjunctivitis Sicca
por: Feinsilber, Doron, et al.
Publicado: (2017)

Clinical‐dosimetric relationship between lacrimal gland dose and keratoconjunctivitis sicca in dogs with sinonasal tumors treated with radiation therapy
por: Poirier, Valerie J., et al.
Publicado: (2020)

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca
por: Sheppard, John, et al.
Publicado: (2021)

Revisiting Keratoconjunctivitis sicca associated with Human T-Cell Lymphotropic Virus Type 1: prevalence, clinical aspects and proviral load
por: Rathsam-Pinheiro, Regina Helena, et al.
Publicado: (2019)

Efficacy and Safety of 0.1% Cyclosporine versus 2% Cyclosporine in the Treatment of Severe Vernal Keratoconjunctivitis in Children
por: Bourcier, Tristan, et al.
Publicado: (2022)

Not all Sicca is Sjögren's and not all Sjögren's is Sicca
por: Neumann, Melissa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uarg02of84rk2l00ndfmfshn4p